FGF2 and neoplasm: As tumours increase in size, the accompanying increased demand for nutrients and oxygen upregulates the excess production of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) from tumour cells, termed the ‘angiogenic switch’ (2).